Tweets by SSO 2024 Annual Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Recorded for On-Demand Viewing

Back

Immunotherapy for Soft-Tissue Sarcoma

Case Based Discussion

Thursday, March 21, 2024

9:45am – 10:15am ET

Location: C105-C106

Panelist(s)

John E. Mullinax, MD

Associate Member
Sarcoma Department, Moffitt Cancer Center
Tampa, Florida, United States
Alexandra Istl, MD MPH (she/her/hers)

Assistant Professor
Medical College of Wisconsin, United States
Edmund Bartlett, MD

Surgical oncologist
MSKCC
New York, New York, United States
Neeta Somaiah, MD (she/her/hers)

Associate Professor of Sarcoma Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Disclosure(s):

John E. Mullinax, MD: Iovance Biotherapeutics: Consultant (Ongoing), Patent Beneficiary (Ongoing), Royalties (Ongoing); Lyell Therapeutics: Consultant (Ongoing); Merit Medical: Consultant (Ongoing); SQZ Therapeutics: Contracted Research (Terminated, November 30, 2023)

Alexandra Istl, MD MPH: No financial relationships to disclose

Edmund Bartlett, MD: Qbiotic Group: Research Grant (Ongoing); SkylineDx: Research Grant (Ongoing)

Neeta Somaiah, MD: Adaptimmune: Advisor (Terminated); Astra Zeneca: Contracted Research (Ongoing); BAYER: Advisor (Terminated); Boehringer-Ingelheim: Advisor (Ongoing); Deciphera: Advisor (Terminated)